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Abstract
Objective To examine yttrium-90 distribution 1 and 72 h
following its injection into a knee joint in patients with
rheumatoid arthritis (RA).
Methods In 14 RA patients we injected yttrium-90 into
the affected knee joint using lateral approach. To assess the
radioisotope distribution in the joint, the superimposed
sequential SPECT and CT imaging was performed 1 and
72 h after the injection. We analyzed the percentage of
radioisotope distribution in three predefined compartments
of the knee joint (lower, upper medial, upper lateral).
Results After 1 and 72 h, the mean percentage distribu-
tions were, respectively, 7.14 and 23.07 % in lower; 21.42
and 15.38 % in upper medial, and 71.42 and 61.53 % in
upper lateral compartment. The percentage of isotope
deposition did not change significantly with time in any of
the compartments (all p [ 0.26). The deposition of isotope,
both at 1 and 72 h, was significantly greater in upper lateral
compartment, where the injection was performed, than in
all other compartments (all p \ 0.05).
Conclusions Using the SPECT/CT hybrid method, we
proved that the majority of isotope is located at the com-
partment adjacent to the injection. Two injections targeting
different compartments might improve the clinical efficacy
of the procedure.
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Introduction
Radiosynoviorthesis (RSO) is a safe and effective thera-
peutic modality for synovitis in inflammatory arthritis [1–
3]. It was developed as an alternative to or preceding the
surgical synovectomy [4]. The main indication is a chronic
synovitis of affected knee in rheumatoid arthritis (RA).
Yttrium-90 (90Y), a radionuclide with an intense b-emis-
sion, is most widely used for the treatment of knee joint.
Efficacy of the RSO is estimated at 60–80 % [3]. However,
the accurate prediction of the efficacy of RSO is difficult
due to patient-related factors such as the type, course, and
inflammatory activity within the joint [2, 5]. On average,
penetration of radiation following RSO approximates
10 mm [6, 7]. Therefore, the efficacy of RSO largely
depends on the radionuclide distribution within the joint.
Single photon emission computed tomography (SPECT/
CT) is a novel hybrid imaging method that combines func-
tional data from SPECT and anatomic data from CT,
sequentially acquired during single examination [8]. SPECT
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creates computer-generated images of radionuclide distri-
bution, while CT enables 3D anatomical images of joint.
The majority of published studies assessed the distri-
bution of radionuclide using gamma camera/SPECT
imaging yielding imprecise information which does not
reflect the uptake of radionuclide into the anatomic com-
partments of the knee. Nevertheless, the gamma camera
imaging provided an evidence that even high degree of
standardization of the procedure, including site of injec-
tion, needle gouge does not prevent unpredictable distri-
bution patterns [9]. Moreover, there are no guidelines for
follow-up time needed to assess RSO efficacy.
The aim of this study was to assess, using SPECT/CT,
the yttrium-90 radionuclide distribution 1 and 72 h fol-
lowing its injection into RA affected knee joint.
Methods
We prospectively enrolled 14 consecutive patients diag-
nosed with RA according to 1987 American College of
Rheumatology criteria [10]. Knee synovitis had to be
present despite treatment with disease-modifying anti-
rheumatic drugs and at least one intra-articular adminis-
tration of long acting steroid. We excluded patients with
ruptured popliteal cyst, pregnant or breast-feeding or
unable to give informed consent.
Procedures
Radiosynoviorthesis
Radiosynoviortheses with beta emitting radionuclide
injected into the knee joint were performed according to
European Association of Nuclear Medicine guidelines [3].
The yttrium-90 (90Y), Colloid CIS bio international colloid
suspension for local injection (IBA Molecular, France),
with mean activity of 220 MBq, was administered into
each predetermined knee. Arthrocentesis of the knee with
1.2 mm-gauge needle was carried out from lateral
approach by experienced rheumatologist. One needle was
used for all intraarticular procedures. Effusion, if present,
was aspirated before radionuclide injection which was
immediately followed by intraarticular administration of
7 mg of betamethasone. After steroid injection the knee
was passively bent several times and splinted for 48 h.
SPECT/CT assessment
In order to assess the radioisotope distribution in the joint
space and to find the possible leakage of radioisotope
outside the joint, the SPECT/CT examinations were
performed. A hybrid system Symbia TruePoint T16 camera
(Siemens) with parallel, medium energy collimators was
used. The yttrium-90 (90Y) tracer was injected in each
target knee. All patients underwent SPECT/CT examina-
tion of the knee 1 and 72 h after the injection of the
radionuclide. Settings of SPECT scan were as follows:
180 orbit for each head, step and shoot mode, 40 images,
at 32 s per view, 128 9 128 matrix. The acquired data
were reconstructed using the ordered subset expectation
maximization (OSEM) FLASH 3D iterative reconstruction
method with eight subsets and ten iterations. Setting of CT
part of the study was as follows: 130 kV, effective mA s
190 with CAREDose4D system, slice thickness 5.0 mm,
acq. 16 9 1.2 mm and reconstruction increment 3.0 mm
with B50s moderate kernel shaped. Each SPECT/CT was
evaluated on an ongoing basis by the medical physicist. In
case of suspicion of leakage of the isotope beyond the joint,
assessment was extended to regional lymph nodes.
Knee joint was divided into three ellipsoid 3D shaped
regions of interest (ROI) according to the predefined ana-
tomical compartments: upper lateral, upper medial and
lower (Fig. 1a). Percentage analysis of radioisotope dis-
tribution in three compartments was performed during
SPECT/CT examinations (each in 72 h apart). The total
amount of injected yttrium-90 (90Y) was considered as
100 %. The number of counts in each ROI was evaluated
using manufacturer provided volumetric analysis. The
percentage of uptake [%] in each region was assessed
according to the formula: [%] = number of counts in the
region/the sum of counts from all regions 9100.
The study was approved by the local bioethics com-
mittee, and written informed consent was obtained prior to
the enrollment.
Statistical analysis
Data were analysed using SAS 9.2 software (SAS Institute
Inc. Cary, NC, USA). First we established the normality of
frequency distributions. Then, we used the Student’s t test
and univariate ANOVA model to check for the between-
compartment, and within-compartment time-related dif-
ferences, respectively.
Results
Mean ± SD age of patients was 53 ± 12 years, with mean
RA duration prior to the study of 5.46 ± 3.31 years. The
mean percentage distributions of the isotope within com-
partments, after 1 and 72 h, respectively, were as follows: in
the lower compartment 7.14 and 23.07 %; in the upper
medial compartment 21.42 and 15.38 %; in the upper lateral
compartment 71.42 and 61.53 %. After 1 h of injection, we
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found significant differences of uptake between compart-
ments, with the greatest percentage of isotope deposition at
the upper lateral compartment which was adjacent to the
injection site (all p \ 0.003), (Table 1). This did not change
materially 72 h post procedure, with significant difference
between the compartment of the injection site and each of the
remaining two (Fig. 2). The percentage of isotope deposition
did not change significantly with time at any of the com-
partments (all p [ 0.26) (Table 1).
Discussion
We found that the distribution of yttrium-90 (90Y) isotope
following its intra-articular injection into the knee joint in
RA patients highly depends on the site of injection. The
deposition was greatest in the upper lateral compartment
into which the isotope was injected, and this did not change
significantly 72 h after the procedure (Fig. 2). The inno-
vative approach of our study was to use the SPECT/CT
Fig. 1 Radioisotope distribution within the knee joint. a Ellipsoid 3D
predefined regions of interest: upper lateral (green), upper medial
(red) and lower (blue) compartments for isotope distribution
measurement. b The example of the average distribution of yttrium-
90 in the knee joint 1 and 72 h after procedure (color figure online)
Table 1 The radioisotope colloid distribution into the knee joint space examined by SPECT/CT method
Patient
no.
Lower compartment Upper medial compartment Upper lateral compartment
T0 (after 1 h) T1 (after 72 h) T0 (after 1 h) T1 (after 72 h) T0 (after 1 h) T1 (after 72 h)
Measured
value
Ratio
(%)
Measured
value
Ratio
(%)
Measured
value
Ratio
(%)
Measured
value
Ratio
(%)
Measured
value
Ratio
(%)
Measured
value
Ratio
(%)
1 187,082.0 17.3 160,291.3 34.0 484,612.4 44.9 166,620.9 35.4 40,858.3 37.8 144,356.6 30.6
2 217,307.1 21.0 127,637.3 28.5 335,644.8 32.5 194,931.8 43.6 480,038.4 46.5 124,793.7 27.9
3 245,048.1 27.2 144,419.4 38.2 343,020.1 38.0 112,091.4 29.6 313,543.0 34.8 121,849.3 32.2
4 64,939.4 7.5 20,950.9 13.7 186,765.1 21.6 26,292.3 17.2 613,708.4 70.9 105,246.2 69.0
5 58,825.2 10.3 64,441.6 17.6 133,025.3 23.3 150,761.8 41.1 378,311.1 66.3 151,367.9 41.3
6 80,293.5 31.2 276,710.3 30.5 96,891.2 37.6 307,239.7 33.8 80,179.1 31.1 324,050.1 35.7
7 73,337.4 28.2 69,108.2 10.1 71,726.6 27.5 279,255.6 40.7 115,310.6 44.3 337,686.4 49.2
8 28,775.6 7.8 21,597.8 9.2 39,720.1 10.7 31,132.0 13.2 302,540.8 81.5 182,240.8 77.6
9 114,714.3 8.0 361,218.5 26.0 905,109.1 66.0
10 72,946.2 9.3 78,084.6 11.4 133,805.9 17.1 141,477.4 20.7 575,082.2 73.6 464,146.0 67.9
11 93,577.8 37.5 44,320.3 42.7 75,823.4 30.4 33,047.0 31.8 79,817.9 32.0 26,398.4 25.4
12 64,144.3 29.6 36,393.9 37.0 63,848.2 29.5 30,732.5 31.2 88,605.2 40.9 31,319.1 31.8
13 17,597.1 6.6 8,672.9 7.5 44,348.0 16.5 18,703.9 16.7 205,999.4 76.9 88,372.5 76.3
14 45,041.6 21.9 24,868.4 32.2 58,956.9 28.7 21,640.9 28.0 101,222.8 49.3 30,667.1 39.7
690 Ann Nucl Med (2014) 28:688–692
123
which enabled accurate anatomical localization of the
deposited isotope (Fig. 1b).
To the best of our knowledge, so far only two studies
assessed the distribution of an isotope, following the
injection into a knee. Jahangier et al. studied 69 patients in
whom RSO was performed [9]. They used the gamma-
camera based detection of the distribution of the isotope,
which does not permit the accurate anatomical visualiza-
tion. They found that in the majority of patients (54 %) the
deposition was diffuse. However, only 28 % of their group
were RA patients. Furthermore, they did not standardize
the time of the assessment, which was performed imme-
diately or 24 h after injection, making it impossible to
study the time-related changes in isotope distribution.
Likewise, Jahangier et al. failed to report whether the
deposition was related to the site of injection. We used a
hybrid method enabling accurate anatomical visualization
of the isotope within a knee which enabled us to prove that
the isotope is deposited predominantly at the site of
injection, which in our study was standardized, and that
deposition does not change after 72 h of follow-up.
Vuorela et al. did a feasibility study on six RA patients
[6]. In order to localize synovitis they administered a
99mTc-immunoglobulin [99mTc-HIG] labeled anti-synovial
antibody. Then they treated the patients with 166 Holmium
ferric hydroxide macroaggregates (166Ho-FHMA), and
reassessed the SPECT/MRI. The authors concluded that the
hybrid method using MRI and SPECT is feasible, and that
the administration of an isotope-labeled antibody can help
localize synovitis. However, the patient was exposed to
two sources of radiation including one injected systemi-
cally (500–550 MBq), and one injected intra-articularly
(0.9–1.0 GBq), and further used gadolinium-enhanced
MRI scanning. We also used the gadolinium-enhanced
MRI to localize synovitis, however, we did not use the
isotope-labeled anti-synovial antibodies. The SPECT/CT
required single source of radiation of 220 MBq, and the CT
equipment we used featured a low-energy scanner.
Our results must be considered within the context of the
study’s limitations. Slight overlapping of ellipsoids is vis-
ible on presented 2D figure (Fig. 1a) but it mostly covers
bone regions or other anatomical structures outside the
joint cavity. The overlap is estimated to be less than 10 %
but might have certain impact on our results.
In conclusion, our data are the first to show, using the
SPECT/CT hybrid method of visualization, the precise
anatomical distribution of injected isotope, and the fact that
the distribution does not change over the standardized, 72 h
time of imaging follow-up. The fact that the majority of
isotope, as opposed to findings by Jahangier et al. is located
close to the site of injection, inclines us to hypothesize that
two injections at two different sites targeting different knee
compartments might improve the distribution of isotope.
Alternatively, a larger volume of radioisotope colloid
suspension might enhance the distribution of yttrium-90
within the knee joint and augment the clinical outcome of
the procedure. However, further studies are needed to
assess these hypotheses.
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